scPharmaceuticals Inc.·4

Dec 20, 4:18 PM ET

SCHAEFFER LEONARD D 4

4 · scPharmaceuticals Inc. · Filed Dec 20, 2017

Insider Transaction Report

Form 4
Period: 2017-12-19
Transactions
  • Exercise/Conversion

    Common Stock

    2017-12-19$1.66/sh+22,631$37,56757,449 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-12-1922,6315,223 total
    Exercise: $1.66Exp: 2024-09-17Common Stock (22,631 underlying)
Holdings
  • Common Stock

    (indirect: By LLC)
    43,104
Footnotes (2)
  • [F1]The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of all of the reported shares for purposes of Section 16 or any other purpose.
  • [F2]25% of the shares vested on September 17, 2015, and an additional 1/48th vests on the last day of each one month period thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION